Celina Dubin MD et al- The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment. A case series study

Celina Dubin MD et al- The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment. A case series study

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this case series study, which was published in the Journal of the American Academy of Dermatology Case Reports. LEARN MORE IN THE FULL ARTICLE IN JAAD CASE REPORTS HERE: https://www.jaadcasereports.org/article/S2352-5126(25)00601-0/fulltext

Celina Dubin MD Shares - Vitiligo and Associated Comorbidities. A Case–Control Study in the US All of Us Database

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this case-control study, published in Clinical and Experimental Dermatology. LEARN MORE ABOUT THIS CASE-CONTROL STUDY IN CED HERE: https://academic.oup.com/ced/article-abstract/50/9/1856/8141161?redirectedFrom=fulltext

Celina Dubin MD - A Phase 2a Trial of Brepocitinib for Cicatricial Alopecia

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this phase 2a trial, which appeared in the Journal of the American Academy of Dermatology. VIEW FULL DETAILS OF THE PHASE 2A TRIAL IN JAAD HERE: https://www.jaad.org/article/S0190-9622(24)03043-3/fulltext

Celina Dubin MD- Vitiligo May Be Associated With an Increased Genetic Risk of Cardiovascular Disease

This research letter was co-authored by Dr. Celina Dubin, MD, a dermatology resident at the Icahn School of Medicine at Mount Sinai, and was published in the Journal of the American Academy of Dermatology International. SEE THE FULL RANDOMIZATION STUDY IN JAAD INTERNATIONAL HERE: https://www.jaadinternational.org/article/S2666-3287(24)00108-1/fulltext

Dr. Celina Dubin, MD-Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, which was published in the Journal of Allergy and Clinical Immunology. The study examines atopic dermatitis (AD), a common inflammatory skin disease that affects up to 10% of adults worldwide. Read the original paper here: https://www.jacionline.org/article/S0091-6749(20)30039-7/fulltext